Johnson & Johnson (JNJ.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap504.06B
Enterprise Value532.28B
P/E Ratio31.24
PEG Ratio-3.87
Price/Sales Ratio6.65
Price/Book Ratio7.76
Enterprise/Revenue6.94
Enterprise/EBITDA20.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.21
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.26

Income Statement

Revenue94.2B
Revenue/Share40.13
Gross Profit68.56B
EBITDA41.06B
Net Income26.81B
Diluted EPS11.03

Balance Sheet

Total Cash20.76B
Total Cash/Share8.51
Total Debt49.04B
Total Debt/Equity0.58
Current Ratio1.09
Book Value Per Share34.82

Price History

52-Week Change50.38
52-Week High241.4
52-Week Low146.98
Moving Average 50 Days221.9
Moving Average 200 Days200.58

Statistics

Average Volume3,347
Shares Outstanding2.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5.24
Trailing Annual Dividend Yield1.94
Payout Ratio0.6
Last Split FactorN/A
Last Split DateN/A
AD